![](https://cdn.grapedrop.com/uf0807162a51541039bfebf48008792f8/45751121ac804befb734d9abb477d0f5_nav-final_gif_-_used_for_signature_logo.gif)
FemSelect is a developer of medical devices designed to treat pelvic organ prolapse disease in women. The company's devices offer a minimally-invasive surgical system for suturing ligaments of the pelvic floor without overnight hospital stays and scars, enabling physicians to conduct surgery without dissection or mesh.
Investment: Series B (Lead)